CH1300646267 - Common Stock

Taking everything into account, **BG** scores **6** out of 10 in our fundamental rating. **BG** was compared to 91 industry peers in the **Food Products** industry. While **BG** belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. **BG** is cheap, but on the other hand it scores bad on growth. With these ratings, **BG** could be worth investigating further for value investing!.

In the past year **BG** had a positive cash flow from operations.

Looking at the **Return On Invested Capital**, with a value of **13.58%**, **BG** belongs to the top of the industry, outperforming **91.11%** of the companies in the same industry.

The 3 year average ROIC (**12.86%**) for **BG** is below the current ROIC(**13.58%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.84% | ||

ROE | 20.67% | ||

ROIC | 13.58% |

ROA(3y)7.99%

ROA(5y)4.3%

ROE(3y)21.59%

ROE(5y)12.18%

ROIC(3y)12.86%

ROIC(5y)10.32%

In the last couple of years the **Profit Margin** of **BG** has grown nicely.

Looking at the **Operating Margin**, with a value of **5.34%**, **BG** is in line with its industry, outperforming **58.89%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **BG** has grown nicely.

Looking at the **Gross Margin**, with a value of **8.15%**, **BG** is doing worse than **75.56%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **BG** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 5.34% | ||

PM (TTM) | 3.77% | ||

GM | 8.15% |

OM growth 3Y17.85%

OM growth 5Y25.08%

PM growth 3Y11.64%

PM growth 5Y49.21%

GM growth 3Y6.61%

GM growth 5Y10.47%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **BG** is creating some value.

Compared to 1 year ago, **BG** has more shares outstanding

Compared to 5 years ago, **BG** has more shares outstanding

An Altman-Z score of **4.34** indicates that **BG** is not in any danger for bankruptcy at the moment.

With a decent **Debt to FCF ratio** value of **2.23**, **BG** is doing good in the industry, outperforming **80.00%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.45 | ||

Debt/FCF | 2.23 | ||

Altman-Z | 4.34 |

ROIC/WACC1.53

WACC8.89%

A Current Ratio of **2.13** indicates that **BG** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.13 | ||

Quick Ratio | 1.2 |

The **Earnings Per Share** has been growing by **38.94%** on average over the past years. This is a very strong growth

The **Revenue** has been growing slightly by **5.41%** on average over the past years.

EPS 1Y (TTM)-18.55%

EPS 3Y19.26%

EPS 5Y38.94%

EPS Q2Q%-23.41%

Revenue 1Y (TTM)-11.44%

Revenue growth 3Y12.87%

Revenue growth 5Y5.41%

Sales Q2Q%-9.27%

Based on estimates for the next years, **BG** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-9.77%** on average per year.

EPS Next Y-29.12%

EPS Next 2Y-16.28%

EPS Next 3Y-9.77%

EPS Next 5YN/A

Revenue Next Year-11.79%

Revenue Next 2Y-6%

Revenue Next 3Y-2.83%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings** ratio is **8.18**, which indicates a very decent valuation of **BG**.

Based on the **Price/Earnings** ratio, **BG** is valued cheaply inside the industry as 96.67% of the companies are valued more expensively.

The **Price/Forward Earnings** ratio is **9.19**, which indicates a very decent valuation of **BG**.

When comparing the **Price/Forward Earnings** ratio of **BG** to the average of the S&P500 Index (**23.56**), we can say **BG** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 8.18 | ||

Fwd PE | 9.19 |

92.22% of the companies in the same industry are more expensive than **BG**, based on the **Enterprise Value to EBITDA** ratio.

Based on the **Price/Free Cash Flow** ratio, **BG** is valued cheaper than 91.11% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 5.62 | ||

EV/EBITDA | 3.34 |

A cheap valuation may be justified as **BG**'s earnings are expected to decrease with **-9.77%** in the coming years.

PEG (NY)N/A

PEG (5Y)0.21

EPS Next 2Y-16.28%

EPS Next 3Y-9.77%

Compared to an average industry **Dividend Yield** of **3.76**, **BG** pays a bit more dividend than its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.13% |

The dividend of **BG** has a limited annual growth rate of **4.77%**.

Dividend Growth(5Y)4.77%

Div Incr Years4

Div Non Decr Years23

DP17.08%

EPS Next 2Y-16.28%

EPS Next 3Y-9.77%

**BUNGE GLOBAL SA**

NYSE:BG (11/14/2024, 8:05:45 PM)

After market: 88.06 0 (0%)**88.06**

**+1.44 (+1.66%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap12.30B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.13% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 8.18 | ||

Fwd PE | 9.19 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.21

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.84% | ||

ROE | 20.67% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 5.34% | ||

PM (TTM) | 3.77% | ||

GM | 8.15% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover2.35

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.45 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.13 | ||

Quick Ratio | 1.2 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-18.55%

EPS 3Y19.26%

EPS 5Y

EPS Q2Q%

EPS Next Y-29.12%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-11.44%

Revenue growth 3Y12.87%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y